🇺🇸 FDA
Patent

US 9399056

Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

granted A61KA61K2039/53A61K2039/884

Quick answer

US patent 9399056 (Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same) held by Inovio Pharmaceuticals, Inc. expires Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue Jul 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/53, A61K2039/884, A61K39/00, A61K39/0011